Pregabalin Completed Phase 4 Trials for Diabetic Neuropathies Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00573261A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy